Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

Market Cap	10.22B
Revenue (ttm)	2.57B
Net Income (ttm)	259.43M
Shares Out	464.53M
EPS (ttm)	0.55
PE Ratio	40.23
Forward PE	27.15
Dividend	0.40 (1.82%)
Ex-Dividend Date	May 20, 2025

Volume	10,088,390
Average Volume	8,118,769
Open	21.77
Previous Close	21.43
Day's Range	21.48 - 22.01
52-Week Range	19.26 - 26.48
Beta	1.12
RSI	67.58
Earnings Date	Apr 23, 2026

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation, diabetes, allergy, respiratory infection, kidney...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 3,197
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300482

Financial Performance

In 2024, SHE:300482's revenue was 3.06 billion, an increase of 10.85% compared to the previous year's 2.76 billion. Earnings were 561.63 million, an increase of 15.18%.